Researchers at Jerusalem’s Hebrew University have developed EvORanker to determine which gene is likely causing a patient’s symptoms. In tests, EvORanker outperformed existing tools, especially when the gene had not previously been linked to disease. https://unitedwithisrael.org/hebrew-university-develops-ai-rare-disease-gene-finder/ https://en.huji.ac.il/news/new-ai-breakthrough-could-change-long-search-rare-disease-diagnoses https://pubmed.ncbi.nlm.nih.gov/38178268/

The Genesis Prize Foundation and the Jewish Funders Network launched a $2 million matching grant program in honor of 2026 Genesis Prize Laureate Gal Gadot (see here previously) to help Israelis deal with emotional and physical trauma since Oct. 7, … Continue reading →

Hebrew University of Jerusalem scientists have compiled a compendium of 2,200 bitter molecules that will help predict bitterness without ever having to taste it. Their research on TAS2R14, a bitter receptor, can help make medicine ‘easier to swallow’ and even … Continue reading →

Staff Sergeant Effi Ben-Yakar, a reservist in a special unit suffered cardiac arrest during leave and passed away at Ichilov Hospital. His lungs went into a 38-year-old woman; his liver into a 71-year-old man and his kidneys into two men, … Continue reading →

Israel’s Silexion Therapeutics (see here previously) received Israeli Ministry of Health approval to initiate a Phase 2/3 trial of SIL204 in locally advanced pancreatic cancer, marking advancement to clinical-stage development. SIL204 targets a range of common KRAS mutations. https://www.stocktitan.net/news/SLXN/silexion-therapeutics-receives-approval-from-israeli-ministry-of-8p7b37yrir10.html

Jerusalem hosted Israel’s premier health-tech conference (March 17–18), showcasing breakthroughs in emergency medicine, ophthalmology and Tech-Bio.  New Israeli technologies for “hospital-at-home” and remote monitoring during emergencies were a core focus. https://export.gov.il/wp-content/uploads/2026/02/MIXIII_BROCHURE_2026.pdf